DNA-PK, ATM and MDR proteins inhibitors in overcoming fludarabine resistance in CLL cells

• Published in: Experimental Oncology
• Date: 2010
• Main Authors: Svirnovski, A.I., Serhiyenka, T.F., Kustanovich, A.M., Khlebko, P.V., Fedosenko, V.V., Taras, I.B., Bakun, A.V.
• Format: Article
• Language: English
• Published: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2010
• Subjects: Original contributions
• Online Access: https://nasplib.isofts.kiev.ua/handle/123456789/32306
• Journal Title: Digital Library of Periodicals of National Academy of Sciences of Ukraine
• Cite this: DNA-PK, ATM and MDR proteins inhibitors in overcoming fludarabine resistance in CLL cells / A.I. Svirnovski, T.F. Serhiyenka, A.M. Kustanovich, P.V. Khlebko, V.V. Fedosenko, I.B. Taras, A.V. Bakun // Experimental Oncology. — 2010. — Т. 32, № 4. — С. 258–262. — Біліогр.: 20 назв. — англ.

The aim of this paper is to perform the comparative study of the effects of DNA-dependent protein kinase (DNA-PK) inhibitors vanillin and NU7026, ataxia telangiectasia mutated kinase (ATM)/ ATM and Rad3 related (ATR) kinase inhibitor caffeine and multidrug resistance (MDR) protein modulator cyclospo...